Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Bacterial Endocarditis HELP
Based on 3,896 articles published since 2008
||||

These are the 3896 published articles about Endocarditis, Bacterial that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). 2018

Chaves, F / Garnacho-Montero, J / Del Pozo, J L / Bouza, E / Capdevila, J A / de Cueto, M / Domínguez, M Á / Esteban, J / Fernández-Hidalgo, N / Fernández Sampedro, M / Fortún, J / Guembe, M / Lorente, L / Paño, J R / Ramírez, P / Salavert, M / Sánchez, M / Vallés, J. ·Servicio de Microbiología, Hospital Universitario 12 de Octubre, Madrid, Spain. · Unidad Clínica de Cuidados Intensivos, Hospital Universitario Virgen Macarena, Sevilla, Spain. Electronic address: jgarnachom@gmail.com. · Área de Enfermedades Infecciosas, Servicio de Microbiología, Clínica Universidad de Navarra, Pamplona, Spain. · Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid; CIBER de Enfermedades Respiratorias, CibeRes, Instituto de Salud Carlos III, Madrid; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. · Servicio de Medicina Interna, Hospital de Mataró, Mataró, Barcelona, Spain. · Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, Spain. · Servicio de Microbiología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. · Departamento de Microbiología Clínica, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain. · Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Servicio de Enfermedades Infecciosas, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Unidad de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Unidad de Enfermedades Infecciosas y Microbiología Clínica, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. · Unidad de Cuidados Intensivos, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. · Unidad de Enfermedades Infecciosas, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain. · Unidad de Cuidados Intensivos, Hospital Universitari i Politècnic La Fe, Valencia; CIBER de Enfermedades Respiratorias (CibeRes), Instituto de Salud Carlos III, Madrid, Spain. · Unidad de Enfermedades Infecciosas, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Servicio de Medicina Intensiva, Hospital Clínico San Carlos, Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. · Unidad de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. ·Med Intensiva · Pubmed #29406956.

ABSTRACT: Catheter-related bloodstream infections (CRBSI) constitute an important cause of hospital-acquired infection associated with morbidity, mortality, and cost. The aim of these guidelines is to provide updated recommendations for the diagnosis and management of CRBSI in adults. Prevention of CRBSI is excluded. Experts in the field were designated by the two participating Societies (the Spanish Society of Infectious Diseases and Clinical Microbiology and [SEIMC] and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units [SEMICYUC]). Short-term peripheral venous catheters, non-tunneled and long-term central venous catheters, tunneled catheters and hemodialysis catheters are covered by these guidelines. The panel identified 39 key topics that were formulated in accordance with the PICO format. The strength of the recommendations and quality of the evidence were graded in accordance with ESCMID guidelines. Recommendations are made for the diagnosis of CRBSI with and without catheter removal and of tunnel infection. The document establishes the clinical situations in which a conservative diagnosis of CRBSI (diagnosis without catheter removal) is feasible. Recommendations are also made regarding empirical therapy, pathogen-specific treatment (coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus spp., Gram-negative bacilli, and Candida spp.), antibiotic lock therapy, diagnosis and management of suppurative thrombophlebitis and local complications.

2 Guideline [European society of cardiology guidelines for the management of infective endocarditis (partim 1)]. 2016

Iovino, A / Marchetta, S / Dulgheru, R / Oury, C / Piérard, L A / Lancellotti, P. ·Service de Cardiologie, CHU de Liège, Belgique. · GIGA Cardiovascular Sciences, Heart Valve Clinic. Service de Cardiologie, CHU de Liège, Belgique. · FRS-FNRS, Université de Liège, GIGA-Sciences Cardiovasculaires, Belgique. · Service des Soins Intensifs Cardiologiques, Service de Cardiologie, CHU de Liège, Belgique. ·Rev Med Liege · Pubmed #28383860.

ABSTRACT: Until recently, the recommendations of infective endocarditis were based on expert opinions, due to its low incidence and the absence of controlled trials. The update in 2015 of the new guidelines of the European Society of Cardiology (compared with 2009) relates to the publication of a randomised study on the surgical treatment, the innovations in imaging procedures (especially functional imaging in nuclear medicine) and the new concept of «Team Endocarditis» (multidisciplinary approach). Their aim is to remind the limitations of antibiotic prophylaxis and to insist on hospital hygiene measures. Future challenges will be to obtain a better understanding of the mechanisms associated with the contamination of the valve and to optimize the adaptation of the current epidemiological prophylaxis. In this first part, we will describe the preventive and diagnostic approaches of infective endocarditis.

3 Guideline Guideline on Antibiotic Prophylaxis for Dental Patients at Risk for Infection. 2016

Anonymous11150889. · ·Pediatr Dent · Pubmed #27931473.

ABSTRACT: -- No abstract --

4 Guideline [Infective endocarditis : New ESC guidelines 2015]. 2016

Plicht, B / Lind, A / Erbel, R. ·Klinik für Kardiologie, Klinikum Westfalen, Am Knappschaftskrankenhaus 1, 44309, Dortmund, Deutschland. bjoern.plicht@klinikum-westfalen.de. · Medizinische Universitätsklinik II, Kardiologie und Angiologie, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum, Deutschland. · Klinik für Kardiologie, Universitätsklinikum Essen, Essen, Deutschland. ·Internist (Berl) · Pubmed #27307162.

ABSTRACT: Infective endocarditis is an endovascular infection usually caused by bacteria. Mortality rate is still approximately 20 %. To improve patients' prognosis by implementation of current diagnostic and therapeutic evidence, the European Society of Cardiology published an updated version of the guidelines for management of infective endocarditis in 2015. It strengthens the role of imaging modalities like PET/CT for detection of infectious foci when echocardiography remains negative and highlights the use of modern tests for identification of possible pathogens. New diagnostic criteria were introduced to integrate these methods for improved diagnostic sensitivity. Complicated cases should be treated in reference centers with on-site cardiac surgery. The antibiotic and early surgical management should be discussed in a multidisciplinary endocarditis team. A few years ago, the indication for endocarditis prophylaxis was limited to high-risk patients. These recommendations were confirmed in current guidelines.

5 Guideline [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. 2016

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Plonska-Gosciniak, Edyta / Price, Susanna / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Tornos Mas, Pilar / Vilacosta, Isidre / Zamorano, Jose Luis / Anonymous3440865. · ·G Ital Cardiol (Rome) · Pubmed #27093212.

ABSTRACT: -- No abstract --

6 Guideline [2015 ESC Guidelines for the management of infective endocarditis]. 2015

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Płońska-Gościniak, Edyta / Price, Sussana / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Mas, Pilar Tornos / Vilacosta, Isidre / Zamorano, Jose Luis. ·gilbert.habib2@gmail.com. ·Kardiol Pol · Pubmed #26726820.

ABSTRACT: -- No abstract --

7 Guideline Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). 2015

Gudiol, Francesc / Aguado, José María / Almirante, Benito / Bouza, Emilio / Cercenado, Emilia / Domínguez, M Ángeles / Gasch, Oriol / Lora-Tamayo, Jaime / Miró, José M / Palomar, Mercedes / Pascual, Alvaro / Pericas, Juan M / Pujol, Miquel / Rodríguez-Baño, Jesús / Shaw, Evelyn / Soriano, Alex / Vallés, Jordi. ·Servicio de Enfermedades Infecciosas, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: jaguadog1@gmail.com. · Servicio de Enfermedades Infecciosas, Hospital Universitario Valle de Hebrón, Barcelona, Spain. · Servicio de Microbiología y Enfermedades Infecciosas, Hospital Universitario Gregorio Marañón, Madrid, Spain. · Servicio de Microbiología, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Departamento de patologia y terapeutica experimental, Universidad de Barcelona, Spain. · Servicio de Enfermedades Infecciosas, Hospital Universitari Parc Taulí, Sabadell, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. · Servicio de Enfermedades Infecciosas, Hospital Clinic - IDIBAPS, Universidad de Barcelona, Barcelona, Spain. · Servicio de Medicina Intensiva, Hospital Arnau de Vilanova, Lleida, Spain. · Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Departamento de Microbiología, Universidad de Sevilla, Spain. · Servicio de Enfermedades Infecciosas, Hospital Clinic IDIBAPS, Barcelona, Spain. · Servicio de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain. ·Enferm Infecc Microbiol Clin · Pubmed #25937457.

ABSTRACT: Both bacteremia and infective endocarditis caused by Staphylococcus aureus are common and severe diseases. The prognosis may darken not infrequently, especially in the presence of intracardiac devices or methicillin-resistance. Indeed, the optimization of the antimicrobial therapy is a key step in the outcome of these infections. The high rates of treatment failure and the increasing interest in the influence of vancomycin susceptibility in the outcome of infections caused by both methicillin-susceptible and -resistant isolates has led to the research of novel therapeutic schemes. Specifically, the interest raised in recent years on the new antimicrobials with activity against methicillin-resistant staphylococci has been also extended to infections caused by susceptible strains, which still carry the most important burden of infection. Recent clinical and experimental research has focused in the activity of new combinations of antimicrobials, their indication and role still being debatable. Also, the impact of an appropriate empirical antimicrobial treatment has acquired relevance in recent years. Finally, it is noteworthy the impact of the implementation of a systematic bundle of measures for improving the outcome. The aim of this clinical guideline is to provide an ensemble of recommendations in order to improve the treatment and prognosis of bacteremia and infective endocarditis caused by S. aureus, in accordance to the latest evidence published.

8 Guideline Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). 2015

Gudiol, Francesc / Aguado, José María / Almirante, Benito / Bouza, Emilio / Cercenado, Emilia / Domínguez, M Ángeles / Gasch, Oriol / Lora-Tamayo, Jaime / Miró, José M / Palomar, Mercedes / Pascual, Alvaro / Pericas, Juan M / Pujol, Miquel / Rodríguez-Baño, Jesús / Shaw, Evelyn / Soriano, Alex / Vallés, Jordi. ·Servicio de Enfermedades Infecciosas, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i + 12, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: jaguadog1@gmail.com. · Servicio de Enfermedades Infecciosas, Hospital Universitario Valle de Hebrón, Barcelona, Spain. · Servicio de Microbiología y Enfermedades Infecciosas, Hospital Universitario Gregorio Marañón, Madrid, Spain. · Servicio de Microbiología, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Spain; Departamento de patología y terapéutica experimental, Universidad de Barcelona, Spain. · Servicio de Enfermedades Infecciosas, Hospital Universitari Parc Taulí, Sabadell, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i + 12, Hospital Universitario 12 de Octubre, Madrid, Spain. · Servicio de Enfermedades Infecciosas, Hospital Clínic - IDIBAPS, Universidad de Barcelona, Barcelona, Spain. · Servicio de Medicina Intensiva, Hospital Arnau de Vilanova, Lleida, Spain. · Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain; Departamento de Microbiología, Universidad de Sevilla, Spain. · Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain; Departamento de Medicina, Universidad de Sevilla, Spain. · Servicio de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain. ·Enferm Infecc Microbiol Clin · Pubmed #25937456.

ABSTRACT: Bacteremia and infective endocarditis caused by Staphylococcus aureus are common and severe diseases. Optimization of treatment is fundamental in the prognosis of these infections. The high rates of treatment failure and the increasing interest in the influence of vancomycin susceptibility in the outcome of infections caused by both methicillin-susceptible and -resistant isolates have led to research on novel therapeutic schemes. The interest in the new antimicrobials with activity against methicillin-resistant staphylococci has been extended to susceptible strains, which still carry the most important burden of infection. New combinations of antimicrobials have been investigated in experimental and clinical studies, but their role is still being debated. Also, the appropriateness of the initial empirical therapy has acquired relevance in recent years. The aim of this guideline is to update the 2009 guidelines and to provide an ensemble of recommendations in order to improve the treatment of staphylococcal bacteremia and infective endocarditis, in accordance with the latest published evidence.

9 Guideline [Clinical guidelines for the prevention of infective endocarditis]. 2014

Pérez-Lescure Picarzo, J / Crespo Marcos, D / Centeno Malfaz, F / Anonymous100755. ·Área de Pediatría y Neonatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España. Electronic address: fjplescure@fhalcorcon.es. · Área de Pediatría y Neonatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España. · Servicio de Pediatría, Hospital Universitario Río Hortega, Valladolid, España. ·An Pediatr (Barc) · Pubmed #23562531.

ABSTRACT: This article sets out the recommendations for the prevention of infective endocarditis (IE), contained in the guidelines developed by the American Heart Association (AHA) and the European Society of Cardiology (ESC), from which the recommendations of the Spanish Society of Paediatric Cardiology and Congenital Heart Disease have been agreed. In recent years, there has been a considerable change in the recommendations for the prevention of IE, mainly due to the lack of evidence on the effectiveness of antibiotic prophylaxis in prevention, and the risk of the development of antibiotic resistance. The main change is a reduction of the indications for antibiotic prophylaxis, both in terms of patients and procedures considered at risk. Clinical practice guidelines and recommendations should assist health professionals in making clinical decisions in their daily practice. However, the ultimate judgment regarding the care of a particular patient must be taken by the physician responsible.

10 Guideline ACOG Practice Bulletin No. 120: Use of prophylactic antibiotics in labor and delivery. 2011

Anonymous3990695. · ·Obstet Gynecol · Pubmed #21606770.

ABSTRACT: -- No abstract --

11 Guideline Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. 2011

Feltes, Timothy F / Bacha, Emile / Beekman, Robert H / Cheatham, John P / Feinstein, Jeffrey A / Gomes, Antoinette S / Hijazi, Ziyad M / Ing, Frank F / de Moor, Michael / Morrow, W Robert / Mullins, Charles E / Taubert, Kathryn A / Zahn, Evan M / Anonymous2500693 / Anonymous2510693 / Anonymous2520693 / Anonymous2530693. · ·Circulation · Pubmed #21536996.

ABSTRACT: -- No abstract --

12 Guideline [Indications for cardiology consultation and management of cardiac patients who will undergo surgical or endoscopic procedures: the proposal of the University Hospital of Trieste, Italy]. 2010

Massa, Laura / Vitrella, Giancarlo / Zecchin, Massimo / Berlot, Giorgio / Bergamini, Pier Riccardo / Pelusi, Lucia / Lattuada, Luca / Sinagra, Gianfranco / Anonymous11370677. ·S.C. di Cardiologia, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Trieste. ·G Ital Cardiol (Rome) · Pubmed #21033337.

ABSTRACT: The number of patients affected by cardiovascular disease admitted to internal medicine and geriatric wards is expanding due to the increasing prevalence of cardiovascular disease in the ageing population. This contributes to a growing demand for cardiology consult visits, with requests for perioperative risk stratification for non-cardiac surgery or endoscopy, and general clinical management. This document was jointly drafted by the Cardiology and Anesthesiology departments, medical and surgical departments, and endoscopy services of the Azienda Ospedaliero-Universitaria "Ospedali Riuniti" in Trieste (Italy). It addresses critical issues such as antiplatelet and anticoagulant therapy in non-cardiac surgery, electric device management, and prophylaxis of bacterial endocarditis. It provides general guidelines and appropriateness criteria, prompted by the Joint Commission International and approved by the Hospital Guidelines Committee. It provides a basis for periodic educational meetings, and will be periodically updated. Periodic audits will monitor its application, and critical and controversial points, in order to promote quality of health care, organizational efficiency, and appropriateness.

13 Guideline Antibiotic prophylaxis in gastrointestinal endoscopy. 2009

Allison, M C / Sandoe, J A T / Tighe, R / Simpson, I A / Hall, R J / Elliott, T S J / Anonymous4210628. ·Gastroenterology Unit, Royal Gwent Hospital, Newport NP20 2UB, UK. milesallison@newport11.fsnet.co.uk ·Gut · Pubmed #19433598.

ABSTRACT: -- No abstract --

14 Guideline [Evaluation of the status of patients with severe infection, criteria for intensive care unit admittance. Spanish Society for Infectious Diseases and Clinical Microbiology. Spanish Society of Intensive and Critical Medicine and Coronary Units]. 2009

Olaechea, Pedro M / Alvarez-Lerma, Francisco / Sánchez, Miguel / Torres, Antonio / Palomar, Mercedes / Fernández, Pedro / Miró, José M / Cisneros, José Miguel / Torres, Manuel / Anonymous6920627 / Anonymous6930627. ·Medicina Intensiva, Hospital de Galdakao, Vizcaya, España. pedromaria.olaecheaastigarrag@osakideta.net ·Enferm Infecc Microbiol Clin · Pubmed #19409668.

ABSTRACT: Recent studies have shown that early attention in patients with serious infections is associated with a better outcome. Assistance in intensive care units (ICU) can effectively provide this attention; hence patients should be admitted to the ICU as soon as possible, before clinical deterioration becomes irreversible. The objective of this article is to compile the recommendations for evaluating disease severity in patients with infections and describe the criteria for ICU admission, updating the criteria published 10 years ago. A literature review was carried out, compiling the opinions of experts from the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC, Spanish Society for Infectious Diseases and Clinical Microbiology) and the Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC, Spanish Society for Intensive Medicine, Critical Care and Coronary Units) as well as the working groups for infections in critically ill patients (GEIPC-SEIMC and GTEI-SEMICYUC). We describe the specific recommendations for ICU admission related to the most common infections affecting patients, who will potentially benefit from critical care. Assessment of the severity of the patient's condition to enable early intensive care is stressed.

15 Guideline [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. 2009

Gudiol, Francisco / Aguado, José María / Pascual, Alvaro / Pujol, Miquel / Almirante, Benito / Miró, José María / Cercenado, Emilia / Domínguez, María de Los Angeles / Soriano, Alex / Rodríguez-Baño, Jesús / Vallés, Jordi / Palomar, Mercedes / Tornos, Pilar / Bouza, Emilio / Anonymous1000623. ·Servicio de Enfermedades Infecciosas, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, España. ·Enferm Infecc Microbiol Clin · Pubmed #19254641.

ABSTRACT: Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA) are prevalent and clinically important. The rise in MRSA bacteremia and endocarditis is related with the increasing use of venous catheters and other vascular procedures. Glycopeptides have been the reference drugs for treating these infections. Unfortunately their activity is not completely satisfactory, particularly against MRSA strains with MICs > 1 microg/mL. The development of new antibiotics, such as linezolid and daptomycin, and the promise of future compounds (dalvabancin, ceftobiprole and telavancin) may change the expectatives in this field.The principal aim of this consensus document was to formulate several recommendations to improve the outcome of MRSA bacteremia and endocarditis, based on the latest reported scientific evidence. This document specifically analyzes the approach for three clinical situations: venous catheter-related bacteremia, persistent bacteremia, and infective endocarditis due to MRSA.

16 Guideline 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 2008

Bonow, Robert O / Carabello, Blase A / Chatterjee, Kanu / de Leon, Antonio C / Faxon, David P / Freed, Michael D / Gaasch, William H / Lytle, Bruce W / Nishimura, Rick A / O'Gara, Patrick T / O'Rourke, Robert A / Otto, Catherine M / Shah, Pravin M / Shanewise, Jack S / Anonymous3120610. · ·J Am Coll Cardiol · Pubmed #18848134.

ABSTRACT: -- No abstract --

17 Guideline [Prevention of endocarditis: changes in the recommendations]. 2008

De Munter, Paul / Peetermans, Willy / Declerck, Dominique / Anonymous37200607. ·Service de Médecine Interne Générale, Cliniques Universitaires Leuven. ·Rev Belge Med Dent (1984) · Pubmed #18754537.

ABSTRACT: Guidelines for the prophylaxis of infective endocarditis have historically evolved and have been based on limited medical evidence. New data suggest that infectious endocarditis is much more likely to result from frequent exposure to random bacteremias associated with daily activities than from bacteremia caused by a dental, gastrointestinal (GI) or genitourinary (GU) tract procedure, that prophylaxis may prevent an exceedingly small number of cases of endocarditis in patients who undergo a dental, GI tract or GU tract procedure and that the risk of antibiotic-associated adverse events may exceed the benefit from prophylactic antibiotic therapy. Based on these data the 2007 guidelines of the American Heart Association radically limit the indications for endocarditis prophylaxis. In its new consensus guidelines, the UZ Leuven restricts candidates for endocarditis prophylaxis to patients with cardiac conditions with an increased risk for infectious endocarditis and the highest risk of an adverse outcome. Prophylaxis is indicated in these patients in case of dental procedures that involve manipulation of gingival tissue, periapical region or in case of perforation of the mucosa. Daily oral hygiene and regular evaluation and treatment by a dentist are essential in the prevention of infectious endocarditis. The publication of these guidelines intends to stimulate discussion in order to develop uniform Belgian guidelines.

18 Guideline Infective endocarditis and the new AHA guideline. 2008

Akpunonu, Basil E / Bittar, Samih / Phinney, Richard C / Taleb, Mohammed. ·Department of Internal Medicine, Ruppert Health Center, University of Toledo, Toledo, OH, USA. ·Geriatrics · Pubmed #18672952.

ABSTRACT: Infective endocarditis (IE) is becoming a disease of the elderly because of the aging process and increased use of intravascular devices. If undetected, IE has a poor prognosis. Previous guidelines had become cumbersome, and with unintended consequences, ie, excess antibiotic use, potential risk for acquisition of multiple-drug-resistant organisms and adverse drug reactions. The newest American Heart Association guideline severely restricts antibiotic prophylaxis, recommending it only for cardiac conditions with the greatest risks for complications and for dental procedures that involve perforation of oral mucosa, manipulation of gingival tissue or periapical region of the teeth. Routine prophylaxis for genitourinary and gastrointestinal procedures is no longer recommended.

19 Guideline ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 2008

Nishimura, Rick A / Carabello, Blase A / Faxon, David P / Freed, Michael D / Lytle, Bruce W / O'Gara, Patrick T / O'Rourke, Robert A / Shah, Pravin M / Bonow, Robert O / Carabello, Blase A / Chatterjee, Kanu / de Leon, Antonio C / Faxon, David P / Freed, Michael D / Gaasch, William H / Lytle, Bruce W / Nishimura, Rick A / O'Gara, Patrick T / O'Rourke, Robert A / Otto, Catherine M / Shah, Pravin M / Shanewise, Jack S / Smith, Sidney C / Jacobs, Alice K / Buller, Christopher E / Creager, Mark A / Ettinger, Steven M / Krumholz, Harlan M / Kushner, Frederick G / Lytle, Bruce W / Nishimura, Rick A / Page, Richard L / Tarkington, Lynn G / Yancy, Clyde W / Anonymous5110604. · ·Circulation · Pubmed #18663090.

ABSTRACT: -- No abstract --

20 Guideline [Guidelines for prevention of infective endocarditis]. 2008

Anonymous4660604 / Anonymous4670604 / Anonymous4680604 / Anonymous4690604 / Gilon, Dan / Zigman-Igra, Yehuda / Metzki, Shlomi / Basra, Jihad / Shiran, Avinoam / Keller, Natan / Levi, Elkat / Litner, Mark. · ·Refuat Hapeh Vehashinayim (1993) · Pubmed #18661803.

ABSTRACT: -- No abstract --

21 Guideline Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. 2008

Wilson, Walter / Taubert, Kathryn A / Gewitz, Michael / Lockhart, Peter B / Baddour, Larry M / Levison, Matthew / Bolger, Ann / Cabell, Christopher H / Takahashi, Masato / Baltimore, Robert S / Newburger, Jane W / Strom, Brian L / Tani, Lloyd Y / Gerber, Michael / Bonow, Robert O / Pallasch, Thomas / Shulman, Stanford T / Rowley, Anne H / Burns, Jane C / Ferrieri, Patricia / Gardner, Timothy / Goff, David / Durack, David T / Anonymous2400589. · ·J Am Dent Assoc · Pubmed #18167394.

ABSTRACT: BACKGROUND: The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis, which were last published in 1997. METHODS: and RESULTS: A writing group appointed by the AHA for their expertise in prevention and treatment of infective endocarditis (IE) with liaison members representing the American Dental Association, the Infectious Diseases Society of America and the American Academy of Pediatrics. The writing group reviewed input from national and international experts on IE. The recommendations in this document reflect analyses of relevant literature regarding procedure-related bacteremia and IE; in vitro susceptibility data of the most common microorganisms, which cause IE; results of prophylactic studies in animal models of experimental endocarditis; and retrospective and prospective studies of prevention of IE. MEDLINE database searches from 1950 through 2006 were done for English language articles using the following search terms: endocarditis, infective endocarditis, prophylaxis, prevention, antibiotic, antimicrobial, pathogens, organisms, dental, gastrointestinal, genitourinary, streptococcus, enterococcus, staphylococcus, respiratory, dental surgery, pathogenesis, vaccine, immunization and bacteremia. The reference lists of the identified articles were also searched. The writing group also searched the AHA online library. The American College of Cardiology/AHA classification of recommendations and levels of evidence for practice guidelines were used. The article subsequently was reviewed by outside experts not affiliated with the writing group and by the AHA Science Advisory and Coordinating Committee. CONCLUSIONS: The major changes in the updated recommendations include the following. (1) The committee concluded that only an extremely small number of cases of IE might be prevented by antibiotic prophylaxis for dental procedures even if such prophylactic therapy were 100 percent effective. (2) IE prophylaxis for dental procedures should be recommended only for patients with underlying cardiac conditions associated with the highest risk of adverse outcome from IE. (3) For patients with these underlying cardiac conditions, prophylaxis is recommended for all dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa. (4) Prophylaxis is not recommended based solely on an increased lifetime risk of acquisition of IE. (5) Administration of antibiotics solely to prevent endocarditis is not recommended for patients who undergo a genitourinary or gastrointestinal tract procedure. These changes are intended to define more clearly when IE prophylaxis is or is not recommended and to provide more uniform and consistent global recommendations.

22 Editorial The Truth Perturbs in the Seemingly Negligible; Brain Magnetic Resonance Imaging and Endocarditis. 2019

Mennander, Ari A. ·Tampere University Heart Hospital and Tampere University, Tampere, Finland. Electronic address: ari.mennander@sydansairaala.fi. ·Semin Thorac Cardiovasc Surg · Pubmed #30529263.

ABSTRACT: -- No abstract --

23 Editorial Stop Draggin' My Heart Around: Recidivism, Intravenous Drug Use, and Endocarditis. 2019

Deas, Dale S / Keeling, Brent. ·Emory University, Division of Cardiothoracic Surgery, Atlanta, Georgia. · Emory University, Division of Cardiothoracic Surgery, Atlanta, Georgia. Electronic address: brent.keeling@emory.edu. ·Semin Thorac Cardiovasc Surg · Pubmed #30278270.

ABSTRACT: -- No abstract --

24 Editorial Bacterial endocarditis after biological pulmonary valve implantation. 2018

Mahfouz, Essam M. ·Mansoura University, Egypt. Electronic address: mahfouzessams@gmail.com. ·Int J Cardiol · Pubmed #30041806.

ABSTRACT: -- No abstract --

25 Editorial Infective endocarditis: Refer for expert team care as soon as possible. 2018

Pettersson, Gosta B / Griffin, Brian / Gordon, Steven M / Blackstone, Eugene H. ·Surgical Director, Adult Congenital Heart Disease Center, Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Pediatric Institute, and Transplant Center, Cleveland Clinic, Cleveland, OH, USA. petterg@ccf.org. · Section Head, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA. · Vice Chair, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA. · Chairman, Department of Infectious Disease, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA. · Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. · Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, and Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. ·Cleve Clin J Med · Pubmed #29733779.

ABSTRACT: -- No abstract --

Next